GALT · Galectin Therapeutics Inc
$3.85
-0.16 (-3.88%)
At close · Jul 21
Market Cap
$253.22M
Shares
65.86M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-23 | — | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-17 | 2026-03-12 | |
| 8-K | 2026-01-21 | 2026-01-16 | |
| 8-K | 2026-01-12 | 2026-01-10 | |
| 8-K | 2025-12-19 | — | |
| 8-K | 2025-12-08 | 2025-12-03 | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| DEF 14A | 2025-10-22 | 2025-12-03 | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-09 | 2025-07-08 | |
| 8-K | 2025-06-16 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-15 | — | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-03-31 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-02-18 | — | |
| 8-K | 2025-01-28 | 2025-01-23 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-20 | — | |
| DEF 14A | 2024-12-03 | 2025-01-23 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-11-14 | — | |
| 8-K | 2024-09-09 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-01 | 2024-07-26 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-03-29 | — | |
| 10-K | 2024-03-29 | 2023-12-31 | |
| 8-K | 2023-12-11 | 2023-12-07 | |
| 8-K | 2023-12-07 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K/A | 2023-11-13 | 2023-08-14 | |
| 8-K | 2023-11-13 | 2023-08-14 | |
| DEF 14A | 2023-10-06 | 2023-12-07 | |
| 10-Q | 2023-08-14 | 2023-06-30 |
Showing 1–50 of 109 filings